No Access
FEATURES
https://doi.org/10.1142/S0219030317000696Cited by:0 (Source: Crossref)
Abstract
A matter of the heart.
Discovering opportunities in China’s cardiovascular market.
Improving outcomes and expanding indications with Transcatheter Aortic Valve Implantation (TAVI).
Community-based cardiac rehabilitation in Singapore.
The gift of life: 50 years of human heart transplant.
Keywords:
- National Heart Research Institute Singapore
- Long QT syndrome
- implantable cardioverter defibrillator
- ICD
- sudden cardiac death
- arrhythmia
- beta–blockers
- Induced Pluripotent Stem Cell technology
- iPSC
- hERG gene
- China’s cardiovascular market
- Solidiance
- CVD drug
- pacemakers
- China healthcare industry
- aortic valve replacement
- Open heart surgery
- Transcatheter Aortic Valve Implantation
- TAVI
- Sapien valve
- CoreValve
- Claret Sentinel
- Medtronic CoreValve Evolut R
- Boston Lotus
- Mount Elizabeth Hospital
- Community
- Cardiovascular Disease
- Cardiac Rehabilitation
- Clinical Outcomes
- Low density lipoprotein
- Singapore Heart Foundation
- human heart transplant
- Christiaan Barnard
- xenotransplantation
- immunosuppressant drugs
- artificial heart
- coronary assist device
